Organon & Co. (OGN) Earnings Date, Estimates & Call Transcripts $9.64 +0.08 (+0.89%) As of 10:15 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Organon & Co. Earnings Summary Organon & Co. issued Q1 2025 earnings on May 1, 2025, reporting an EPS of $1.02, which topped the consensus estimate of $0.89 by $0.13. Quarterly revenue fell 6.7% year-over-year to $1.51 billion, below analysts' expectations of $1.53 billion. With a trailing EPS of $2.88 and a P/E Ratio of 3.34, Organon & Co.'s earnings are expected to grow 1.63% next year, from $3.68 to $3.74 per share. Upcoming Q2 Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (May. 1) $0.89 Actual EPS (May. 1) $1.02 Beat By $0.13 Actual Revenue (May. 1) $1.51BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)SEC FilingOGN Upcoming EarningsOrganon & Co.'s Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Organon & Co. Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organon & Co. and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Organon & Co. Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $3.68 EPSNext Year EPS Consensus Estimate $3.74 EPS Organon & Co. Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)-------5/1/2025Q1 2025$0.89$1.02+$0.13$0.33$1.53B$1.51B2/13/2025Q4 2024$0.92$0.83 -$0.09$0.42$1.57B$1.59B10/31/2024Q3 2024$0.90$0.87 -$0.03$0.24$1.56B$1.58B8/6/2024Q2 2024$1.08$1.12+$0.04$1.31$1.61B$1.61B5/2/2024Q1 2024$0.83$1.14+$0.31$1.50$1.57B$1.62B2/15/2024Q4 2023$0.73$0.87+$0.14-$0.39$1.55B$1.60B11/2/2023Q3 2023$1.04$0.78 -$0.26$1.33$1.59B$1.52B8/8/2023Q2 2023$0.97$1.31+$0.34$1.67$1.57B$1.61B Organon & Co. Earnings - Frequently Asked Questions When is Organon & Co.'s earnings date? Organon & Co. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on OGN's earnings history. What guidance has Organon & Co. issued on next quarter's earnings? Organon & Co. updated its FY 2025 earnings guidance on Thursday, May, 1st. The company issued revenue guidance of $6.1 billion-$6.3 billion, compared to the consensus revenue estimate of $6.3 billion. Did Organon & Co. beat their earnings estimates last quarter? In the previous quarter, Organon & Co. (NYSE:OGN) reported $1.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.89 by $0.13. Learn more on analysts' earnings estimate vs. OGN's actual earnings. How can I listen to Organon & Co.'s earnings conference call? The conference call for Organon & Co.'s latest earnings report can be listened to online. Listen to Conference Call How can I read Organon & Co.'s conference call transcript? The conference call transcript for Organon & Co.'s latest earnings report can be read online. Read Transcript How can I view Organon & Co.'s earnings report? Organon & Co.'s earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Organon & Co. generate each year? Organon & Co. (NYSE:OGN) has a recorded annual revenue of $6.40 billion. How much profit does Organon & Co. generate each year? Organon & Co. (NYSE:OGN) has a recorded net income of $864 million. OGN has generated $2.88 earnings per share over the last four quarters. What is Organon & Co.'s price-to-earnings ratio? Organon & Co. (NYSE:OGN) has a trailing price-to-earnings ratio of 3.32 and a forward price-to-earnings ratio of 2.60. The price/earnings-to-growth ratio is 1.02. What is Organon & Co.'s EPS forecast for next year? Organon & Co.'s earnings are expected to grow from $3.68 per share to $3.74 per share in the next year, which is a 1.63% increase. More Earnings Resources from MarketBeat Related Companies Blueprint Medicines Earnings Date BridgeBio Pharma Earnings Date Verona Pharma PLC American Depositary Share Earnings Date Roivant Sciences Earnings Date Elanco Animal Health Earnings Date Revolution Medicines Earnings Date Legend Biotech Earnings Date Grifols Earnings Date TG Therapeutics Earnings Date Nuvalent Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NYSE:OGN) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
